The remaining 13 patients (6%) met the definition of probable late Lyme disease with patient-reported symptoms and positive IgG immunoblot, but without a history of previously physician-documented ...
This webinar will describe the potential diagnostic benefits of using the dissociated VIDAS Lyme IgM II and VIDAS Lyme IgG II assays in a 2-tier EIA approach versus the use of the standard EIA / ...